AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)

AbCellera Biologics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.01 for Q1 2025.

• Quarterly Debt Ratio fell 81.44% year-over-year to 0.01 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.01 (down 81.44% YoY) and the FY2024 annual result came in at 0.01, down 82.48% from the prior year.
• Debt Ratio was 0.01 for Q1 2025 at AbCellera Biologics, up from 0.01 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.04 in Q2 2023 and bottomed at 0.01 in Q4 2024.
• A 5-year average of 0.02 and a median of 0.02 in 2021 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 113.92% — and 2024, when it sank 82.48%.
• AbCellera Biologics' Debt Ratio stood at 0.02 in 2021, then soared by 64.96% to 0.03 in 2022, then advanced by 18.22% to 0.03 in 2023, then plunged by 82.48% to 0.01 in 2024, then increased by 9.78% to 0.01 in 2025.
• Business Quant data shows ABCL's Debt Ratio at 0.01 in Q1 2025, 0.01 in Q4 2024, and 0.01 in Q3 2024.